BioForce Announces Placement of a NanoArrayer™ System
News Sep 06, 2005
BioForce Nanosciences has announced placement of a NanoArrayer™ System at North Carolina State University in the laboratory of Dr. Dan Feldheim, Professor of Chemistry.
"The NanoArrayer System provides a unique solution to the problem Dr. Feldheim faces of ultramicro-scale deposition of femtoliter volumes on specialized surfaces developed in his laboratory," noted Dr. Eric Henderson, Founder and CEO at BioForce Nanosciences.
He adds, "In addition to providing this technology, we will also be working with this research group at a collaborative level as they further develop their powerful and novel molecular screening process."
Dr. Feldheim is working with a team of researchers to discover RNA sequences that catalyze the formation of nanomaterials. The team, which includes Professor Bruce Eaton at The University of Colorado, recently found that certain RNA sequences catalyze the formation of new forms of metallic nanoparticles, compositions that may be useful in alternative energy and medical imaging technologies.
Bruce is also excited about implementing this system noting "the Bioforce NanoArrayer System will increase the pace of discovery of catalytically active RNA sequences tremendously."
"This technology has significant market potential in several areas including Molecular Diagnostics, Molecular Detection and Pharma Discovery," observed Dr. Curtis Mosher, Vice President of Research and Development.
Previous work by the International Multiple Sclerosis Genetics Consortium (IMSGC) has identified 233 genetic risk variants. However, these only account for about 20% of overall disease risk, with the remaining genetic culprits proving elusive. A new study has tracked down four of these hard-to-find genes.READ MORE